LYN-00201

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameLYN-00201
Drug Alias NameLYN-00201
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVascular endothelial growth factor receptor 2 antagonistsVascular endothelial growth factor receptor 3 antagonistsVascular endothelial growth factor receptor 1 antagonists
TargetsVascular endothelial growth factor receptor 2Vascular endothelial growth factor receptor 1Vascular endothelial growth factor receptor 3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLynkcell Inc
China Registration ClassN/A

Develop Information

Active CompaniesLynkcell Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A